fish meme
Thrivent Financial for Lutherans lowered its position in shares of Inari Medical, Inc. ( NASDAQ:NARI – Free Report ) by 8.4% during the 3rd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 39,351 shares of the company’s stock after selling 3,603 shares during the quarter. Thrivent Financial for Lutherans owned 0.07% of Inari Medical worth $1,623,000 as of its most recent filing with the Securities & Exchange Commission. A number of other hedge funds and other institutional investors have also recently modified their holdings of the business. Lighthouse Investment Partners LLC purchased a new stake in shares of Inari Medical during the second quarter valued at approximately $2,145,000. Aigen Investment Management LP purchased a new stake in shares of Inari Medical during the 3rd quarter valued at $428,000. Integral Health Asset Management LLC increased its position in shares of Inari Medical by 100.0% during the 2nd quarter. Integral Health Asset Management LLC now owns 400,000 shares of the company’s stock valued at $19,260,000 after purchasing an additional 200,000 shares during the last quarter. The Manufacturers Life Insurance Company raised its stake in shares of Inari Medical by 1,219.9% during the 2nd quarter. The Manufacturers Life Insurance Company now owns 394,901 shares of the company’s stock worth $19,014,000 after purchasing an additional 364,983 shares during the period. Finally, Financial Enhancement Group LLC purchased a new position in shares of Inari Medical in the 3rd quarter worth about $1,155,000. Hedge funds and other institutional investors own 90.98% of the company’s stock. Insider Activity at Inari Medical In other news, CFO Mitch C. Hill sold 3,000 shares of the business’s stock in a transaction on Thursday, September 12th. The shares were sold at an average price of $45.13, for a total transaction of $135,390.00. Following the completion of the transaction, the chief financial officer now directly owns 179,600 shares in the company, valued at $8,105,348. The trade was a 1.64 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link . Also, Director William Hoffman sold 60,000 shares of the company’s stock in a transaction on Monday, November 18th. The stock was sold at an average price of $51.16, for a total transaction of $3,069,600.00. Following the completion of the transaction, the director now directly owns 501,233 shares in the company, valued at approximately $25,643,080.28. The trade was a 10.69 % decrease in their position. The disclosure for this sale can be found here . In the last three months, insiders have sold 186,000 shares of company stock worth $8,990,990. 10.60% of the stock is owned by company insiders. Inari Medical Price Performance Analysts Set New Price Targets A number of analysts recently issued reports on the stock. Canaccord Genuity Group raised their price objective on shares of Inari Medical from $71.00 to $74.00 and gave the stock a “buy” rating in a report on Tuesday, October 29th. Piper Sandler raised their price target on shares of Inari Medical from $50.00 to $52.00 and gave the stock a “neutral” rating in a research note on Tuesday, October 29th. Stifel Nicolaus started coverage on shares of Inari Medical in a report on Tuesday, September 17th. They issued a “hold” rating and a $50.00 price target on the stock. Needham & Company LLC reissued a “hold” rating on shares of Inari Medical in a report on Tuesday, October 29th. Finally, Leerink Partners assumed coverage on Inari Medical in a research report on Tuesday, September 3rd. They issued a “market perform” rating and a $47.00 target price for the company. Six investment analysts have rated the stock with a hold rating and five have issued a buy rating to the company’s stock. According to MarketBeat.com, Inari Medical presently has a consensus rating of “Hold” and an average target price of $58.89. View Our Latest Stock Report on NARI About Inari Medical ( Free Report ) Inari Medical, Inc builds minimally invasive, novel, and catheter-based mechanical thrombectomy devices and accessories for the specific disease states in the United States. The company provides ClotTriever system, which is designed to core, capture, and remove large clots from large vessels for treatment of deep vein thrombosis and peripheral thrombus; FlowTriever system, a large bore catheter-based aspiration and mechanical thrombectomy system to remove large clots from large vessels in the peripheral vasculature for treating pulmonary embolism and other complex venous thromboembolism cases; InThrill system to treat small vessel thrombosis; and LimFlow system for patients who have chronic limb-threatening ischemia with no suitable endovascular or surgical revascularization options and risk of major amputation. Further Reading Five stocks we like better than Inari Medical EV Stocks and How to Profit from Them The Latest 13F Filings Are In: See Where Big Money Is Flowing What is the Dogs of the Dow Strategy? Overview and Examples 3 Penny Stocks Ready to Break Out in 2025 What Investors Need to Know About Upcoming IPOs FMC, Mosaic, Nutrien: Top Agricultural Stocks With Big Potential Receive News & Ratings for Inari Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Inari Medical and related companies with MarketBeat.com's FREE daily email newsletter .
TTM Technologies, Inc. Introduces Innovative Radio Frequency Components for Telecom Band n104 to Enhance 5.5G ApplicationsInsurTech Market to Grow by USD 77.41 Billion (2024-2028), Driven by Business Efficiency Needs and AI Impacting Market Trends - TechnavioRemember Y2K? It was 1999 and many were sure civilization was about to end
S&P/TSX composite, U.S. markets trade lower Friday morning after holiday breakLawmakers impeach president
Thrivent Financial for Lutherans cut its stake in shares of Inari Medical, Inc. ( NASDAQ:NARI – Free Report ) by 8.4% in the 3rd quarter, HoldingsChannel reports. The firm owned 39,351 shares of the company’s stock after selling 3,603 shares during the period. Thrivent Financial for Lutherans’ holdings in Inari Medical were worth $1,623,000 at the end of the most recent reporting period. Other hedge funds and other institutional investors have also bought and sold shares of the company. GAMMA Investing LLC raised its position in shares of Inari Medical by 164.7% during the 2nd quarter. GAMMA Investing LLC now owns 704 shares of the company’s stock valued at $34,000 after buying an additional 438 shares in the last quarter. Nisa Investment Advisors LLC increased its stake in Inari Medical by 83.5% in the second quarter. Nisa Investment Advisors LLC now owns 956 shares of the company’s stock valued at $46,000 after acquiring an additional 435 shares during the last quarter. KBC Group NV raised its position in Inari Medical by 39.0% during the third quarter. KBC Group NV now owns 1,774 shares of the company’s stock valued at $73,000 after purchasing an additional 498 shares in the last quarter. Benjamin F. Edwards & Company Inc. lifted its stake in Inari Medical by 39.4% during the second quarter. Benjamin F. Edwards & Company Inc. now owns 1,847 shares of the company’s stock worth $89,000 after purchasing an additional 522 shares during the last quarter. Finally, Covestor Ltd boosted its holdings in shares of Inari Medical by 63.5% in the 3rd quarter. Covestor Ltd now owns 2,384 shares of the company’s stock worth $99,000 after purchasing an additional 926 shares in the last quarter. Hedge funds and other institutional investors own 90.98% of the company’s stock. Analysts Set New Price Targets A number of analysts recently weighed in on NARI shares. Deutsche Bank Aktiengesellschaft began coverage on Inari Medical in a research report on Friday, August 9th. They issued a “buy” rating and a $68.00 target price for the company. Stifel Nicolaus started coverage on shares of Inari Medical in a research note on Tuesday, September 17th. They set a “hold” rating and a $50.00 price target on the stock. Canaccord Genuity Group upped their price objective on shares of Inari Medical from $71.00 to $74.00 and gave the company a “buy” rating in a research note on Tuesday, October 29th. Truist Financial lifted their target price on shares of Inari Medical from $46.00 to $50.00 and gave the stock a “hold” rating in a research report on Tuesday, October 29th. Finally, Robert W. Baird boosted their price target on shares of Inari Medical from $66.00 to $67.00 and gave the stock an “outperform” rating in a research note on Tuesday, October 29th. Six analysts have rated the stock with a hold rating and five have assigned a buy rating to the company. According to MarketBeat.com, the company currently has an average rating of “Hold” and an average price target of $58.89. Insider Buying and Selling at Inari Medical In related news, Director William Hoffman sold 40,000 shares of the firm’s stock in a transaction dated Monday, September 16th. The stock was sold at an average price of $45.83, for a total value of $1,833,200.00. Following the sale, the director now directly owns 643,296 shares of the company’s stock, valued at $29,482,255.68. This trade represents a 5.85 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link . Also, CFO Mitch C. Hill sold 3,000 shares of the company’s stock in a transaction that occurred on Thursday, September 12th. The shares were sold at an average price of $45.13, for a total value of $135,390.00. Following the transaction, the chief financial officer now directly owns 179,600 shares of the company’s stock, valued at $8,105,348. The trade was a 1.64 % decrease in their position. The disclosure for this sale can be found here . Over the last quarter, insiders have sold 186,000 shares of company stock worth $8,990,990. 10.60% of the stock is currently owned by company insiders. Inari Medical Stock Up 1.7 % NASDAQ:NARI opened at $51.92 on Friday. The firm has a market capitalization of $3.04 billion, a P/E ratio of -38.46 and a beta of 0.96. The company has a fifty day moving average of $46.14 and a 200 day moving average of $47.48. Inari Medical, Inc. has a 52 week low of $36.73 and a 52 week high of $67.13. Inari Medical Company Profile ( Free Report ) Inari Medical, Inc builds minimally invasive, novel, and catheter-based mechanical thrombectomy devices and accessories for the specific disease states in the United States. The company provides ClotTriever system, which is designed to core, capture, and remove large clots from large vessels for treatment of deep vein thrombosis and peripheral thrombus; FlowTriever system, a large bore catheter-based aspiration and mechanical thrombectomy system to remove large clots from large vessels in the peripheral vasculature for treating pulmonary embolism and other complex venous thromboembolism cases; InThrill system to treat small vessel thrombosis; and LimFlow system for patients who have chronic limb-threatening ischemia with no suitable endovascular or surgical revascularization options and risk of major amputation. Further Reading Want to see what other hedge funds are holding NARI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Inari Medical, Inc. ( NASDAQ:NARI – Free Report ). Receive News & Ratings for Inari Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Inari Medical and related companies with MarketBeat.com's FREE daily email newsletter .I remember where I was when I first heard the term. It was early 1998 and I was in a McDonald's drive-thru. My friend was explaining to me why he and his family had decided to move to rural Arkansas next year. "Y2K," I said. "What's that?" ADVERTISEMENT Y2K. The "millenium bug" arriving in the year 2000. The new millennium. Some of you might well remember this time. For those under about age 30, let me catch you up. Many of the computers used in government and business in the late 20th century, including ones that powered the early internet, supposedly had something of a ticking time bomb inside of them. "It's very hard to tell how bad the situation will be. I'm sure things will break. It's very hard to dispel a nightmare scenario," Nathan Myhrvold, Microsoft's chief technology officer, was cited as saying in a January 1999 Forum column. "The dark-side scenario of airplanes falling out of the sky and bank computers crashing is possible. But it's fundamentally very, very hard to know whether the impact will be big or little." The problem was the two-digit-year date field (think "93" as in "1/1/93"). Theoretically, the arrival of the new millennium — the year 2000 — would reset all these computer clocks to "00" as in "1/1/00," wrecking anything that counted on dates to function properly. Theoretically, anyway. The list of public fears was a long one, illustrating how central computer technology had become in our lives, and mirroring larger uncertainty about the new millennium. And while company officials and local, state and federal officials sought to reassure the public, ongoing reporting indicated nobody was quite sure nothing would fail. So the fears remained up until the last minute. ADVERTISEMENT "Up against the deadline for fixing an unprecedented technological blunder, the world exhibited some jitters Thursday over the prospect of failures in the computers on which we depend," wrote the Associated Press, as printed by The Forum on New Year's Eve, 1999. "There was testing galore and a few confessions of Y2K-unreadiness." Some religious figures took the moment to insist the coming apocalypse was God's judgment on a wayward culture. "(God) may be preparing to confound our language, to jam our communications, scatter our efforts and judge us for our sin and rebellion against his lordship," evangelical Christian leader Jerry Falwell said in August 1998. "We are hearing from many sources that Jan. 1, 2000, will be a fateful day in the history of the world." As if to embody the looming fears, WWE wrestler Chris Jericho gave himself the moniker Y2J (for Jericho), playing off the Y2K term. His entrance to arenas was marked by a countdown video that, when it got to zero, included shutting off the venue lights, leaving people in noisy darkness before Jericho was revealed. As the year 2000 approached, the fears began to grow into something of a hysteria for some people, sparking drastic decisions, like my friend's family's decision to move to the woods. Others took money out of the bank. Some stocked up on supplies and guns and ammunition to survive the coming failure of civilization. The growing fears were in odd juxtaposition to the more joyful expressions by some about the year 2000. Big millennium parties were planned. Monopoly put out a millennium edition with fancy holographic cards. The boy band Backstreet Boys released their "Millennium" album, still iconic among my generation (OK, fine — I'm listening to it right now). Many people dismissed the fears and planned to go about their lives, expecting the furor was overblown. ADVERTISEMENT I moved from North Dakota to South Dakota in 1999, and as the new millennium approached, I was about 55% convinced Y2K was going to cause big problems. I remember counting down the last days of the 1900s and thinking everything was possibly about to change. It didn't, of course. While there were some hiccups among some computer systems, much of the billions of dollars in preparation worked. A concerted global effort to stave off disaster was effective. The apocalypse never arrived, civilization continued. In fact, my daughter was born later that year — one of many "millennium" babies who are now 24 years old. So what happened to my friend who moved to Arkansas? I don't know. I'd like to think he and his family went on to live their best life in a cabin in the Ozarks, ready for the end of the world that never arrived. Have a moment or person in history that you think is especially interesting? Contact me at jfugleberg@forumcomm.com and tell me why you think it would be a great subject for this column.